Figure 8. rCV02 increased the levels of synaptic proteins in the brains of 3 × Tg-AD mice.
3 × Tg-AD mice were immunized with rCV02 at 3 months (prophylactic; panel A and C) or 12 months (therapeutic; panels B and D) of age. The brains were collected for evaluation at 19 months and 21 months of age, respectively. Levels of dynamin 1 (A,B) and PSD-95 (C,D) in the soluble fractions of the brain homogenates were detected by Western blot analysis; representative images are shown (lanes 1–3, non-vaccinated control 3 × Tg-AD; lanes, 4–6 rCV01-vaccinated 3 × Tg-AD; lanes 6–9, non-vaccinated control C57/BL6). The graphs show the levels of dynamin 1 (A, B) and PSD-95 (C,D) in control and treated mice. Data represent the mean ± SE for each group. Statistically significant differences were determined by ANOVA. *p < 0.05, **p < 0.01, compared with the control group (3 × Tg-AD).